Figure 2From: Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malariaObserved and predicted median plasma concentration of clindamycin (by one compartment open model with first-order absorption and elimination with absorption lag time) given as combination therapy with fosmidomycin (600 mg every 12 hours for 7 days).Back to article page